申请人:Hoffmann-La Roche Inc.
公开号:US06281363B1
公开(公告)日:2001-08-28
Hydrazine derivatives and their pharmaceutically acceptable salts useful for the treatment of inflammatory and autoimmune diseases, osteoarthritis, respiratory diseases, tumors, cachexia, cardiovascular disease, fever, hemorrhage, and sepsis.
肼衍生物及其药用可接受盐,用于治疗炎症和自身免疫性疾病、骨关节炎、呼吸系统疾病、肿瘤、消瘦症、心血管疾病、发热、出血和败血症。